Publication | Closed Access

Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine

Continuation/maintenance Phase TreatmentPsychiatryMood SymptomDepressionMajor Depressive DisorderRehabilitationPsychiatric DisorderMental HealthRelapse PreventionMedicinePsychopathologyResidual Symptom